Ginkgo Bioworks logoCompany profile

Ginkgo Bioworks

Ginkgo Bioworks, founded in 2008, has raised $796M to date from investors including Illumina, Viking Global, Felicis Ventures, Gates Foundation, and NSF grants. The Boston-based synthetic-biology company programs microbes for flavors, fragrances, sweeteners, agricultural inputs, and biopharma partnerships. Its platform combines high-throughput biology, automation, and software to accelerate R&D and commercialize bio-manufactured products. Funding and grants have supported platform scaling, foundry automation, and product commercialization. Ginkgo is positioned to expand industrial and consumer synthetic biology solutions globally while optimizing large-scale bio-manufacturing efficiency.

Back to profiles

Quick facts

Total funding
$796M
Founded
2008

Notable investors

  • Illumina
  • Viking Global
  • Felicis Ventures
  • Gates Foundation
  • NSF grants

Reach buyers like Ginkgo Bioworks.

The 14-day trial ships every feature, no card required.